A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2002
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156129 Method of treating pruritus and a pharmaceutical composition for the method
10/24/2002	US20020156124 Paclitaxel, a solvent, a surfactant, a substituted cellulosic polymer, and a P-glycoprotein inhibitor; supersaturation of a microemulsion upon contact with water
10/24/2002	US20020156116 Antiproliferative agents for disorders with GRB-2 adaptor protein function; treating diabetes, insulin resistance, insulin deficiency and insulin allergy
10/24/2002	US20020156109 1,4-dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety
10/24/2002	US20020156104 Novel pyrazole and pyrazoline substituted compounds
10/24/2002	US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002	US20020156100 1-deoxy-galactonojirimycin and related compounds used to treat fabry disease
10/24/2002	US20020156099 1-acyl-piperidine substance p antagonist; used to treat central nervous system disorders and respiratory diseases
10/24/2002	US20020156097 Pharmaceuticals
10/24/2002	US20020156094 Sulfonamide interleukin-1beta converting enzyme inhibitors
10/24/2002	US20020156090 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
10/24/2002	US20020156089 Use of CRF antagonists and related compositions
10/24/2002	US20020156085 1,4-Disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156078 Use of molindone to treat oppositional defiant disorder and conduct disorder
10/24/2002	US20020156076 Imidazole derivatives used to reduce ocular pressure or treat glaucoma and other diseases
10/24/2002	US20020156074 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors
10/24/2002	US20020156071 Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors
10/24/2002	US20020156069 Benzo thiadiazine matrix metalloproteinase inhibitors
10/24/2002	US20020156061 Administering to a mammal a matrix metalloproteinase inhibiting amount of derivatives of isophthalic acid, isophthalic acid ester or isothalamide compounds to treat cancer, rheumatic arthritis atherosclerosis and osteoporosis
10/24/2002	US20020156053 Treating gastro-oesophageal reflux disease
10/24/2002	US20020156051 Atherosclerosis and hyperlipidemia; ascorbic acid and anticholesterol agents that are 3-hydroxy-3-methyl glutaryl coenzyme-A reductase inhibitors
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002	US20020156045 Magnesium chloride improves efficiency of transfection of polynucleotide; drug delivery; vaccination
10/24/2002	US20020156035 NET-4 is a member of the tetraspan transmembrane receptor family; antisense molecules, ribozymes, antibodies and antibody fragments for reductin NET-4 gene expression or activity; antitumor agents
10/24/2002	US20020156031 A DNA segment comprising a protein coding region encoding an Osterix polypeptide; gene therapy; osteoporosis; recombinant Osterix polypeptide
10/24/2002	US20020156024 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/24/2002	US20020156019 Method of optimizing growth hormone replacement
10/24/2002	US20020156013 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
10/24/2002	US20020156000 Inhibiting NF-kappa B-dependent target gene expression in a cell.
10/24/2002	US20020155998 Erythropoietin analog-human serum albumin fusion
10/24/2002	US20020155990 Method of optimizing growth hormone replacement
10/24/2002	US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy
10/24/2002	US20020155545 Chemokines expressed in pancreas
10/24/2002	US20020155539 Calcium channel polynucleotides, polypeptides, and antibodies
10/24/2002	US20020155534 SBHWSB2: a new member of the WD40 SOCS box family
10/24/2002	US20020155503 Method for mapping the active sites bound by enzymes that covalently modify substrate molecules
10/24/2002	US20020155470 Intercalation compound for use in the diagnosis and detection of genetic disorders
10/24/2002	US20020155447 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/24/2002	US20020155432 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/24/2002	US20020155426 Prevention and treatment of amyloid-associated disorders
10/24/2002	US20020155144 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/24/2002	US20020155094 Method of treating sepsis and ARDS using chemokine beta-9
10/24/2002	EP1212298A4 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine
10/24/2002	CA2763637A1 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002	CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002	CA2447008A1 Controlled delivery of tetracycline compounds and tetracycline derivatives
10/24/2002	CA2444932A1 Aromatase inhibition to enhance assisted reproduction
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002	CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	CA2444267A1 Prodrugs of cox-2 inhibitors
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002	CA2444253A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae
10/24/2002	CA2444247A1 Inhibitors of integrin .alpha.v.beta.6
10/24/2002	CA2444164A1 Pufa polyketide synthase systems and uses thereof
10/24/2002	CA2444047A1 Methods to inhibit viral replication
10/24/2002	CA2444026A1 Mutants of desoxycytidine kinase having extended enzymatic activity
10/24/2002	CA2444001A1 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
10/24/2002	CA2443923A1 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
10/24/2002	CA2443874A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	CA2443805A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	CA2443777A1 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	CA2443734A1 Method of inhibiting adhesion formation
10/24/2002	CA2443733A1 Peptide antiangiogenic drugs
10/24/2002	CA2443732A1 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002	CA2443699A1 Phenyl heterocyclyl ether
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002	CA2443655A1 Tropane alkaloid multidrug resistance inhibitors from erythroxylum pervillei and use of the same
10/24/2002	CA2443639A1 Compositions containing imidazotriazinone for nasal application
10/24/2002	CA2443568A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	CA2443565A1 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
10/24/2002	CA2443564A1 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
10/24/2002	CA2443559A1 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application
10/24/2002	CA2443525A1 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections
10/24/2002	CA2443490A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
10/24/2002	CA2443487A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2443234A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	CA2442943A1 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
10/24/2002	CA2442264A1 A method of treating cancer
10/24/2002	CA2441274A1 Aurones as telomerase inhibitors
10/24/2002	CA2440842A1 Novel 1h-indazole compounds
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	WO2001080854A1 Activators for peroxisome proliferator-activated receptor
10/23/2002	EP1251131A2 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
10/23/2002	EP1251128A1 Cyclohexylamine derivatives as subtype selective N-methyl-D-aspartate antagonists
10/23/2002	EP1251125A2 New camptothecin analogues, preparation methods thereof, use thereof as drugs, and pharmaceutical compositions containing them
10/23/2002	EP1250934A1 Anticancer compositions
10/23/2002	EP1250930A2 Mixture of herbs as ATP synthesis activator
10/23/2002	EP1250927A2 Pharmaceutical composition for topical application comprising nifedipine
10/23/2002	EP1250923A2 Use of selective PDE10 inhibitors for the treatment of central nervous system disorders
10/23/2002	EP1250849A1 Morinda citrifolia (Noni) enhanced animal food product
10/23/2002	EP1250600A2 Diagnosis of tauopathies determining tau/phospho-tau ratio
10/23/2002	EP1250422A2 Myeloid colony stimulating factor and uses thereof
10/23/2002	EP1250358A1 Therapeutic peptides

1 ... 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 ... 1564